<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.0" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">jkra</journal-id>
<journal-title-group>
<journal-title>The Journal of the Korean Rheumatism Association</journal-title>
<abbrev-journal-title>J Korean Rheum Assoc</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1226-8070</issn>
<issn pub-type="epub">2233-4718</issn>
<publisher>
<publisher-name>The Korean Rheumatism Association</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.4078/jkra.2007.14.4.401</article-id>
<article-id pub-id-type="publisher-id">jkra-14-401</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Rapidly Progressive Interstitial Lung Disease Associated with Dermatomyositis; A Case Report</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Yoon</surname><given-names>Jae Young</given-names></name><degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff1-jkra-14-401"/>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Min</surname><given-names>Sun Yang</given-names></name><degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff1-jkra-14-401"/>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Park</surname><given-names>Ju Yee</given-names></name><degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff1-jkra-14-401"/>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Hong</surname><given-names>Seung Goun</given-names></name><degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff1-jkra-14-401"/>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Kang</surname><given-names>Hyo Jong</given-names></name><degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff1-jkra-14-401"/>
</contrib>
<aff id="aff1-jkra-14-401">Department of Internal Medicine, Bundang Jesaeng General Hospital, Seongnam, Korea</aff>
</contrib-group>
<pub-date pub-type="ppub"><month>12</month><year>2007</year></pub-date>
<pub-date pub-type="epub"><day>23</day><month>12</month><year>2007</year></pub-date>
<volume>14</volume>
<issue>4</issue>
<fpage>401</fpage>
<lpage>406</lpage>
<history>
<date date-type="received"><day>07</day><month>08</month><year>2007</year></date>
<date date-type="revised"><day>24</day><month>08</month><year>2007</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2007 The Korean Rheumatism Association</copyright-statement>
<copyright-year>2007</copyright-year>
<license><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license>
</permissions>
<abstract xml:lang="en">
<title>Abstract</title>
<p>A previously healthy 44-year-old woman who was diagnosed as having dermatomyositis suddenly developed severe dyspnea while being in the state of improved condition of muscle weakness. Interstitial lung disease was found on high resolution computed tomography (HRCT). In spite of the treatment with the immune-modulating agent (high dose steroid, cyclopho- sphamide, immunoglubulin and cyclosporine), her condition deteriorated further and rapidly, leading to death. More intensive agent such as FK506 would be necessary in those cases of dermatomyositis-related interstitial lung disease that have poor prognostic factors.</p>
</abstract>
<kwd-group xml:lang="en">
<kwd>Interstitial lung disease</kwd>
<kwd>Dermatomyositis</kwd>
</kwd-group>
</article-meta>
</front>
<back>
<ref-list xml:lang="en"><title>REFERENCES</title>
<ref id="b1"><element-citation publication-type="journal"><label>1)</label><person-group person-group-type="author"><name><surname>Dalakas</surname> <given-names>MC</given-names></name> <name><surname>Hohlfeld</surname> <given-names>R</given-names></name></person-group> <article-title>Polymyositis and dermatomyositis</article-title> <source>Lancet</source> <year>2003</year> <volume>362</volume> <fpage>971</fpage><lpage>82</lpage></element-citation></ref>
<ref id="b2"><element-citation publication-type="journal"><label>2)</label><person-group person-group-type="author"><name><surname>Kurasawa</surname> <given-names>K</given-names></name> <name><surname>Nawata</surname> <given-names>Y</given-names></name> <name><surname>Takabayashi</surname> <given-names>K</given-names></name> <name><surname>Kumano</surname> <given-names>K</given-names></name> <name><surname>Kita</surname> <given-names>Y</given-names></name> <name><surname>Takiguchi</surname> <given-names>Y</given-names></name> <etal/></person-group> <article-title>Activation of pulmonary T cells in corticosteroid-resistant and-sensitive interstitial pneumonitis in dermatomyositis/polymyositis</article-title> <source>Clin Exp Immunol</source> <year>2002</year> <volume>129</volume> <fpage>541</fpage><lpage>8</lpage></element-citation></ref>
<ref id="b3"><element-citation publication-type="journal"><label>3)</label><collab>&#xAE40;&#xD604;&#xC219;: &#xC11C;&#xC218;&#xD64D;: &#xD5C8;&#xC9C0;&#xC548;: &#xACFD;&#xC2B9;&#xAE30;: &#xC8FC;&#xC9C0;&#xD604;: &#xC724;&#xC885;&#xD604;&#xB4F1;</collab> <article-title>&#xC5FC;&#xC99D;&#xC131;&#xADFC;&#xC721;&#xBCD1;&#xC99D;&#xC5D0;&#xB3D9;&#xBC18;&#xB41C;&#xD3D0;&#xCE68;&#xBC94;&#xC758;&#xC784;&#xC0C1;&#xC801;&#xD2B9;&#xC9D5;</article-title> <source>&#xB300;&#xD55C;&#xB958;&#xB9C8;&#xD2F0;&#xC2A4;&#xD559;&#xD68C;&#xC9C0;</source> <year>2007</year> <volume>14</volume> <fpage>15</fpage><lpage>22</lpage></element-citation></ref>
<ref id="b4"><element-citation publication-type="journal"><label>4)</label><person-group person-group-type="author"><name><surname>Nawata</surname> <given-names>Y</given-names></name> <name><surname>Kurasawa</surname> <given-names>K</given-names></name> <name><surname>Takabayashi</surname> <given-names>K</given-names></name> <name><surname>Miike</surname> <given-names>S</given-names></name> <name><surname>Watanabe</surname> <given-names>N</given-names></name> <name><surname>Hiraguri</surname> <given-names>M</given-names></name> <etal/></person-group> <article-title>Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine</article-title> <source>J Rheumatol</source> <year>1999</year> <volume>26</volume> <fpage>1527</fpage><lpage>33</lpage></element-citation></ref>
<ref id="b5"><element-citation publication-type="journal"><label>5)</label><person-group person-group-type="author"><name><surname>Maeda</surname> <given-names>K</given-names></name> <name><surname>Kimura</surname> <given-names>R</given-names></name> <name><surname>Komuta</surname> <given-names>K</given-names></name> <name><surname>Igarashi</surname> <given-names>T</given-names></name></person-group> <article-title>Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?</article-title> <source>Scand J Rheumatol</source> <year>1997</year> <volume>26</volume> <fpage>24</fpage><lpage>9</lpage></element-citation></ref>
<ref id="b6"><element-citation publication-type="journal"><label>6)</label><person-group person-group-type="author"><name><surname>Miyazaki</surname> <given-names>E</given-names></name> <name><surname>Ando</surname> <given-names>M</given-names></name> <name><surname>Muramatsu</surname> <given-names>T</given-names></name> <name><surname>Fukami</surname> <given-names>T</given-names></name> <name><surname>Matsuno</surname> <given-names>&#x110B;</given-names></name> <name><surname>Nureki</surname> <given-names>S</given-names></name> <etal/></person-group> <article-title>Early assessment of rapidly progressive interstitial pneumonia associated with amyopathic dermatomyositis</article-title> <source>Clin Rheumatol</source> <year>2005</year> <volume>26</volume> <fpage>436</fpage><lpage>9</lpage></element-citation></ref>
<ref id="b7"><element-citation publication-type="journal"><label>7)</label><person-group person-group-type="author"><name><surname>Maryam</surname> <given-names>F</given-names></name> <name><surname>Ingrid</surname> <given-names>E</given-names></name></person-group> <article-title>Interstitial lung disease in polymyositis and dermatomyositis</article-title> <source>Curr &#x110B;pin Rheumatol</source> <year>2005</year> <volume>17</volume> <fpage>701</fpage><lpage>6</lpage></element-citation></ref>
<ref id="b8"><element-citation publication-type="journal"><label>8)</label><collab>&#xBC15;&#xADFC;&#xBBFC;: &#xCD5C;&#xCC3D;&#xBBFC;: &#xC5C4;&#xC0C1;&#xC6D0;: &#xD669;&#xC6A9;&#xC77C;: &#xC784;&#xC7AC;&#xC900;: &#xC774;&#xC7AC;&#xD638;&#xB4F1;</collab> <article-title>&#xD3D0;&#xB97C;&#xCE68;&#xBC94;&#xD55C;&#xD53C;&#xBD80;&#xADFC;&#xC5FC;/&#xB2E4;&#xBC1C;&#xC131;&#xADFC;&#xC5FC;&#xC758;&#xC784;&#xC0C1;&#xC801;&#xC591;&#xC0C1;</article-title> <source>&#xACB0;&#xD575;&#xBC0F;&#xD638;&#xD761;&#xAE30;&#xC9C8;&#xD658;</source> <year>2001</year> <volume>51</volume> <fpage>354</fpage><lpage>63</lpage></element-citation></ref>
<ref id="b9"><element-citation publication-type="journal"><label>9)</label><person-group person-group-type="author"><name><surname>Marie</surname> <given-names>I</given-names></name> <name><surname>Hachulla</surname> <given-names>E</given-names></name> <name><surname>Cherin</surname> <given-names>P</given-names></name> <name><surname>Dominique</surname> <given-names>S</given-names></name> <name><surname>Hatron</surname> <given-names>PY</given-names></name> <name><surname>Hellot</surname> <given-names>MF</given-names></name> <etal/></person-group> <article-title>Intersitial lung disease in polymyositis and dermatomyositis</article-title> <source>Arthritis Rheum</source> <year>2002</year> <volume>40</volume> <fpage>614</fpage><lpage>22</lpage></element-citation></ref>
<ref id="b10"><element-citation publication-type="journal"><label>10)</label><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>EH</given-names></name> <name><surname>Lee</surname> <given-names>EB</given-names></name> <name><surname>Shin</surname> <given-names>KC</given-names></name> <name><surname>Im</surname> <given-names>CH</given-names></name> <name><surname>Chung</surname> <given-names>DH</given-names></name> <name><surname>Han</surname> <given-names>SK</given-names></name> <etal/></person-group> <article-title>Interstitial lung disease and amyopathic dermatomyositis</article-title> <source>Rheumatology</source> <year>2005</year> <volume>44</volume> <fpage>1282</fpage><lpage>6</lpage></element-citation></ref>
<ref id="b11"><element-citation publication-type="journal"><label>11)</label><person-group person-group-type="author"><name><surname>&#x110B;ddis</surname> <given-names>CV</given-names></name> <name><surname>Sciurba</surname> <given-names>FC</given-names></name> <name><surname>Elmaqd</surname> <given-names>KA</given-names></name> <name><surname>Starzl</surname> <given-names>TE</given-names></name></person-group> <article-title>Tacrolimus in refractory polymyositis with interstitial lung disease</article-title> <source>Lancet</source> <year>1999</year> <volume>22</volume> <fpage>1763</fpage><lpage>4</lpage></element-citation></ref>
<ref id="b12"><element-citation publication-type="journal"><label>12)</label><person-group person-group-type="author"><name><surname>Takada</surname> <given-names>K</given-names></name> <name><surname>Nagasaka</surname> <given-names>K</given-names></name> <name><surname>Miyasaka</surname> <given-names>N</given-names></name></person-group> <article-title>Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants</article-title> <source>Autoimmunity</source> <year>2005</year> <volume>38</volume> <fpage>383</fpage><lpage>92</lpage></element-citation></ref>
<ref id="b13"><element-citation publication-type="journal"><label>13)</label><person-group person-group-type="author"><name><surname>Fathi</surname> <given-names>M</given-names></name> <name><surname>Lundberg</surname> <given-names>IE</given-names></name></person-group> <article-title>Interstitial lung disease in polymyositis and dermatomyositis</article-title> <source>Curr &#x110B;pin Rheumatol</source> <year>2005</year> <volume>17</volume> <fpage>701</fpage><lpage>6</lpage></element-citation></ref>
<ref id="b14"><element-citation publication-type="journal"><label>14)</label><person-group person-group-type="author"><name><surname>Huh</surname> <given-names>JW</given-names></name> <name><surname>Kim</surname> <given-names>DS</given-names></name> <name><surname>Lee</surname> <given-names>CK</given-names></name> <name><surname>Yoo</surname> <given-names>B</given-names></name> <name><surname>Seo</surname> <given-names>JB</given-names></name> <name><surname>Kitaichi</surname> <given-names>M</given-names></name> <etal/></person-group> <article-title>Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis</article-title> <source>Respir Med</source> <year>2007</year> <volume>101</volume> <fpage>1761</fpage><lpage>9</lpage></element-citation></ref></ref-list>
<sec sec-type="display-objects">
<title>Figures</title>
<fig id="f1-jkra-14-401" position="anchor">
<label>Fig. 1.</label>
<caption><p>Heliotrope rash which is considered pathognomonic cutaneous features of dermatomyositis.</p></caption>
<graphic xlink:href="jkra-14-401f1.tif"/>
</fig>
<fig id="f2-jkra-14-401" position="anchor">
<label>Fig. 2.</label>
<caption><p>(A) Poikilodermatous lesions on the back at the first presentation. (B) Gottron&#x0027;s papules appeared two months later after initial presentation.</p></caption>
<graphic xlink:href="jkra-14-401f2.tif"/>
</fig>
<fig id="f3-jkra-14-401" position="anchor">
<label>Fig. 3.</label>
<caption><p>Increased signal intensity in vastus intermedius, vastus lateralis, rectus femoris muscle, semitendinosus sartorius and short head muscle of biceps femoris on transverse (A) and coronal (B) view of fat suppressed T1-weighted MR images.</p></caption>
<graphic xlink:href="jkra-14-401f3.tif"/>
</fig>
<fig id="f4-jkra-14-401" position="anchor">
<label>Fig. 4.</label>
<caption><p>(A) The chest HRCT shows ground glass opacity along the bronchovascular bundle in both lung fields and small subpleural nodules in right upper segment. (B) Chest x-ray shows ground glass opacity in both lung fields on one day before she expired.</p></caption>
<graphic xlink:href="jkra-14-401f4.tif"/>
</fig>
</sec>
</back>
</article>
